Ronald Muhlenkamp
Muhlenkamp & Co
Muhlenkamp & Co Portfolio 13F
Ronald Muhlenkamp Holdings Activity
- Portfolio value:
- $228.82M≈ (+$24M≈)
- Previous value:
- $205.12M≈
- # of changes:
- 36
- New positions:
- 5
- Reported for:
- 31 Dec 2019 (Q4)
- Latest filing date:
- 20 Feb 2020
Muhlenkamp & Co has disclosed a total of 36 changes to the portfolio in the (2019 Q4) SEC report(s): increased the number of shares of 18, bought 5 totally new, decreased the number of shares of 11 and completely sold out 2 position(s).
What stocks did Ronald Muhlenkamp buy in 2019 Q4?
During 2019 Q4 Ronald Muhlenkamp has bought 23 securities out of which top 5 purchases (by % change to portfolio) were (GLD) SPDR Gold Shares (added shares +0.08%), (RUSHA) Rush Enterprises A Inc (added shares +0.04%), (MCK) McKesson Corp (reduced shares 0.00%), (DOW) Dow Inc (added shares +295.35%) and (AMLP) Alerian MLP ETF (added shares +20.45%).
In the 2019 Q4 report(s) the following changes have been made to the top investments: (AAPL) Apple Inc (reduced shares -6.43%), (MSFT) Microsoft Corp (reduced shares -8.22%), (GLD) SPDR Gold Shares (added shares +0.08%), (RUSHA) Rush Enterprises A Inc (added shares +0.04%) and (MCHP) Microchip Technology Inc (reduced shares -0.06%).
36 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lennar Corp
|
new
|
$55.79
|
+51.41%($84.47)
|
2.24%
|
2019 Q4
|
≈ 0.25 years
|
||||
|
|
TENNECO INC, CL-A
|
new
|
$13.10
|
|
2.14%
|
2019 Q4
|
≈ 0.25 years
|
||||
|
|
Rush Enterprises B Inc
|
new
|
$30.40
|
+160.37%($79.15)
|
0.09%
|
2019 Q4
|
≈ 0.25 years
|
||||
|
|
BRISTOL-MYERS SQUIBB-CVR
|
new
|
$3.01
|
|
0.09%
|
2019 Q4
|
≈ 0.25 years
|
||||
|
|
Bristol-Myers Squibb Company
|
new
|
$64.19
|
+1.05%($64.86)
|
3.46%
|
2019 Q4
|
≈ 0.25 years
|
||||
|
|
Dow Inc
|
+295.35%
|
$54.73
|
-44.83%($30.20)
|
3.56%
|
2019 Q2
|
≈ 0.75 years
|
||||
|
|
Invesco BuyBack Achievers ETF
|
+104.44%
|
$68.98
|
+114.04%($147.64)
|
1.94%
|
2014 Q3
|
≈ 5.25 years
|
||||
|
|
CVS Health Corp
|
+52.09%
|
$74.29
|
+41.71%($105.28)
|
3.46%
|
2019 Q3
|
≈ 0.50 years
|
||||
|
|
JAZZ PHARMACEUTICALS PLC
|
+36.93%
|
$149.28
|
+69.03%($252.32)
|
3.24%
|
2018 Q2
|
≈ 1.50 years
|
||||
|
|
Alerian MLP ETF
|
+20.45%
|
$8.50
|
+545.19%($54.84)
|
3.50%
|
2018 Q1
|
≈ 1.75 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.